Comparative Cost-Effectiveness Research Easier Said Than Done – Experts
This article was originally published in The Tan Sheet
Executive Summary
Determining the comparative value of medical treatments sounds like a good idea, if researchers could agree on how to do it
You may also be interested in...
Comparative Effectiveness Language Clarified In Compromise Stimulus Bill
Congress took steps in its final version of the economic stimulus package to alleviate concerns that the comparative effectiveness research provisions will lead to the government making cost-based comparisons or making coverage and reimbursement decisions based on the research
CMS Urged To Cover Beta Amyloid PET Scans For Alzheimer's, But Cautiously
Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.
French Firm Explores U.S. Regulatory Strategy For Blood-based Alzheimer’s Test
With a CE mark in hand, Exonhit is training its sights on the U.S. market. A 160-patient pilot study conducted through the Cleveland Clinic completed enrollment a few weeks ago.